XTL BIOPHARMACEUTICALS LTD - XTLB
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | History | New | 42,531 | 102 | 0.0% | — | 1 | +42,531 | New | Q3 2026 | Nov 16, 2026 |
| RHUMBLINE ADVISERS | History | Added to | 6,871 | 16 | 0.0% | 0.0% | 2 | +643 | 10.32% | Q3 2026 | Nov 10, 2026 |
| GAMMA Investing LLC | History | Added to | 3,436 | 7 | 0.0% | 0.0% | 3 | +2,223 | 183.26% | Q3 2026 | Oct 08, 2026 |
| UBS Group AG | History | Added to | 427 | 0 | — | — | — | +302 | 241.6% | Q3 2026 | Nov 10, 2026 |
| ROYAL BANK OF CANADA | History | New | 100 | 0 | — | — | — | +100 | New | Q3 2026 | Nov 16, 2026 |